E-LIB Suche - Ergebnisse für: Willemze, Roelof

1

Survival Improvement over Time of 960 s-AML Patients Includ..:

Ramadan, Safaa M. ; Suciu, Stefan ; Stevens-Kroef, Marian J. P. L....
Cancers. 12 (2020) 11 - p. 3334 , 2020

Link: https://doi.org/10.3390/..

2

Impact of the type of anthracycline and of stem cell transp..:

Baron, Frédéric ; Efficace, Fabio ; Cannella, Laura...
American Journal of Hematology. 95 (2020) 7 - p. 749-758 , 2020

Link: https://doi.org/10.1002/..

3

Cytogenetic clonal heterogeneity is not an independent prog..:

Baron, Frédéric ; Stevens-Kroef, Marian ; Kicinski, Michal...
Annals of Hematology. 97 (2018) 10 - p. 1785-1795 , 2018

Link: https://doi.org/10.1007/..

4

Mixed T cell receptor dimers harbor potentially harmful neo..:

van Loenen, Marleen M. ; de Boer, Renate ; Amir, Avital L....
Proceedings of the National Academy of Sciences. 107 (2010) 24 - p. 10972-10977 , 2010

Link: https://doi.org/10.1073/..

5

Mixed T cell receptor dimers harbor potentially harmful neo..:

van Loenen, Marleen M. ; de Boer, Renate ; Amir, Avital L....
Proceedings of the National Academy of Sciences of the United States of America. 107 (2010) 24 - p. 10972-10977 , 2010

Link: https://www.jstor.org/st..

6

Nonexpanded primary lung and bone marrow–derived mesenchyma..:

in 't Anker, Pieternella S ; Noort, Willy A ; Kruisselbrink, Alwine B...
Experimental Hematology. 31 (2003) 10 - p. 881-889 , 2003

Link: https://doi.org/10.1016/..

7

Survival Improvement over Time of 960 s-AML Patients Includ..:

Ramadan, Safaa M ; Suciu, Stefan ; Stevens-Kroef, Marian J. P. L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697114/. , 2020

Link: http://www.ncbi.nlm.nih...

8

Survival Improvement over Time of 960 s-AML Patients Includ..:

Ramadan, Safaa M ; Suciu, Stefan ; Stevens-Kroef, Marian J. P. L...
urn:issn:2072-6694. , 2020

Link: https://orbi.uliege.be/h..

9

Survival improvement over time of 960 s-AML patients includ..:

Ramadan, Safaa M ; Suciu, Stefan ; Stevens-Kroef, Marian J. P. L...
https://freidok.uni-freiburg.de/data/169791. , 2020

Link: https://freidok.uni-frei..

10

Impact of induction regimen and allogeneic hematopoietic ce..:

Baron, Frédéric ; Stevens-Kroef, Marian ; Kicinski, Michal...
info:eu-repo/semantics/altIdentifier/pmid/30523055. , 2019

Link: http://hdl.handle.net/11..

11

Cytogenetic clonal heterogeneity is not an independent prog..:

Baron, Frédéric ; Stevens-Kroef, Marian ; Kicinski, Michal...
urn:issn:0939-5555. , 2018

Link: https://orbi.uliege.be/h..

12

Low-dose clofarabine in combination with a standard remissi..:

Selleslag, Dominik ; Suciu, Stefan ; Meloni, Giovanna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286953/. , 2017

Link: http://www.ncbi.nlm.nih...

13

Low-dose clofarabine in combination with a standard remissi..:

Selleslag, Dominik ; Suciu, Stefan ; Meloni, Giovanna...
urn:issn:0390-6078. , 2017

Link: https://orbi.uliege.be/h..

14

Improved overall survival with Gemtuzumab Ozogamicin (GO) c..:

AMADORI, Sergio ; SUCIU, Stefan ; SELLESLAG, Dominik...
urn:issn:0006-4971. , 2014

Link: https://orbi.uliege.be/h..

15

High-Dose Cytarabine in Induction Treatment Improves the Ou..:

Willemze, Roelof ; Suciu, Stefan ; Meloni, Giovanna...
urn:issn:0732-183X. , 2014

Link: https://orbi.uliege.be/h..